Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: Mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention

Medicine & Life Sciences

• Chemoprevention 100%
• Gastritis 97%
• Cyclooxygenase 2 94%
• Helicobacter pylori 87%
• Cyclooxygenase 2 Inhibitors 52%
• Safety 52%
• Helicobacter Infections 38%
• Prostaglandins 33%
• Neoplasms 28%
• Stomach 25%
• rofecoxib 25%
• Ulcer 16%
• Stomach Neoplasms 15%
• Mucous Membrane 14%
• Pyloric Antrum 12%
• Cyclooxygenase 1 11%
• Cyclooxygenase Inhibitors 10%
• Uncertainty 8%
• Healthy Volunteers 5%
• Cell Proliferation 5%
• Biomarkers 5%
• Biopsy 5%
• Drug Therapy 5%